Article Details
Retrieved on: 2021-05-04 16:45:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
An experimental monoclonal antibody treatment for COVID-19 being developed by Eli Lilly and Co and AbCellera Biologics Inc can "potently" neutralize ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here